• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

PTE (Pulmonary Thromboendarterectomy) Surgery

CTEPH or chronic thromboembolic pulmonary hypertension is a potentially curable form of pulmonary hypertension. The possible cure is an intense surgery called PTE or pulmonary thromboendarterectomy. The goal of PTE is to remove blood clots from arteries in the lungs. Removing the clots allows for blood to flow from the right side of the heart through the lungs and back to the left side of the heart without increased pressure. The results are improved oxygenation of the entire body and decreased work load on the right side of the heart.

What Should I Expect During Evaluation for PTE Surgery?

Reviewing PAH DiagnosisThe first step of treating CTEPH is to receive an appropriate diagnosis by a Pulmonary Hypertension or CTEPH expert. A PH Center of Excellence will be able to screen for and diagnose CTEPH via VQ scan and or pulmonary angiography. Because the PTE surgery is very delicate and difficult it is important to work with your PAH provider to carefully choose which center to go to. Centers of Excellence have been recognized for their programs that promote best practices in patient care, quality, and safety. These centers have years of experience performing hundreds of PTEs per year. Their outcomes are superior to centers with less experience. We refer our patients to UC San Diego.

Once the referral has been made to the PTE specialty center a coordinator from that program will reach out to the patient and give instructions on filling out appropriate paperwork that they will require. The physician making the referral will have already sent medical records to the PTE center. The PTE team will inform the patient and their physician if any additional tests are necessary to determine candidacy for surgery. Depending on the location of the center and the cost/convenience of visiting the center an appointment may be set up to meet the PTE team and discuss the surgery, other patients will meet the PTE team just prior to surgery. It is important to work with the center to plan the approximate 3 week stay that will be required for surgery and recovery.

Not all patients will be good candidates for PTE. Patients with comorbidities such as pulmonary fibrosis may not qualify. Other patients have inoperable CTEPH meaning the clots are too numerous and possibly in the smaller blood vessels of the lungs that cannot be adequately accessed by surgery.

How is PTE Surgery Performed?

The pulmonary thromboendarterectomy is an 8-10 hour surgery. The patient’s chest is opened through their sternum. The right and left pulmonary arteries are addressed one at a time. A small incision is made in the pulmonary artery and the old blood clots that are compressed against the wall of the blood vessel are carefully removed. The fibrotic old clotted material is meticulously dissected as completely as possible. At times during the procedure, the patient’s heart is stopped, and the patient is placed on a heart-lung bypass machine. They are cooled to a hypothermic level to protect their organs during the periods when the heart is stopped and the brain and body are supported by the heart-lung bypass machine.  You can watch a video of Dr. Michael Madani of UC San Diego performing PTE surgery by clicking here.

What Happens After PTE Surgery?

PAH Expert talking with PH patientFollowing the surgery the patient will be transported from the operating room to the cardiac intensive care unit. They will be there for 3-10 days before transferring to a medical floor of the hospital. After a few more days the patient will be allowed to leave the hospital but will be required to come back for daily exams and blood tests to make sure their blood thinners are at the appropriate level. Generally patients are allowed to return home after about 3 weeks.

CTEPH patients with a successful PTE will often return home off of PAH therapies. They will require blood thinners for the rest of their life to prevent chronic clots from reforming.

What If The PTE Surgery Doesn’t Work?

For some CTEPH patients PTE surgery improves symptoms but doesn’t cure their pulmonary hypertension. These patients have persistent CTEPH. Other patients develop new chronic clots and have recurrent CTEPH after surgery. These patients like all CTEPH patients will be treated with blood thinners. They may also be placed on Adempas, the only FDA approved medication for CTEPH as well as other PAH treatments not specifically designed for CTEPH.

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Delivery of PAH medications

Winter Weather Causes Shipping Delays For PAH Medications

By Dr. Jeremy Feldman

The United States is getting hit with brutal severe winter weather this year and the country held their breath when UPS

echocardiogram to assess PAH patient

FAQ’s: Mild Pulmonary Hypertension?

By Dr. Jeremy Feldman

We receive many questions about the significance of an echocardiogram that shows mild “pulmonary hypertension”. When

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives